ID   PTPRC_RAT               Reviewed;        1273 AA.
AC   P04157;
DT   01-NOV-1986, integrated into UniProtKB/Swiss-Prot.
DT   12-JUN-2007, sequence version 2.
DT   02-OCT-2024, entry version 216.
DE   RecName: Full=Receptor-type tyrosine-protein phosphatase C;
DE            EC=3.1.3.48;
DE   AltName: Full=Leukocyte common antigen;
DE            Short=L-CA;
DE   AltName: Full=T200;
DE   AltName: CD_antigen=CD45;
DE   Flags: Precursor;
GN   Name=Ptprc;
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 1-147 (ISOFORM 4).
RG   Amgen EST program;
RT   "Amgen rat EST program.";
RL   Submitted (MAY-2003) to the EMBL/GenBank/DDBJ databases.
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 19-218 (ISOFORMS 1; 2; 3 AND 4).
RX   PubMed=2440674; DOI=10.1002/j.1460-2075.1987.tb02362.x;
RA   Barclay A.N., Jackson D.I., Willis A.C., Williams A.F.;
RT   "Lymphocyte specific heterogeneity in the rat leucocyte common antigen
RT   (T200) is due to differences in polypeptide sequences near the NH2-
RT   terminus.";
RL   EMBO J. 6:1259-1264(1987).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 19-1273 (ISOFORMS 1; 3; 4 AND 5).
RA   Barclay A.N., Jackson D.I., Willis A.C., Williams A.F.;
RL   Submitted (MAY-1987) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 208-1255 (ISOFORM 1).
RX   PubMed=3158393; DOI=10.1016/0092-8674(85)90063-7;
RA   Thomas M.L., Barclay A.N., Gagnon J., Williams A.F.;
RT   "Evidence from cDNA clones that the rat leukocyte-common antigen (T200)
RT   spans the lipid bilayer and contains a cytoplasmic domain of 80,000 Mr.";
RL   Cell 41:83-93(1985).
RN   [5]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-652; SER-963; SER-966;
RP   SER-970; SER-973; SER-974; SER-978 AND SER-1209, AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=22673903; DOI=10.1038/ncomms1871;
RA   Lundby A., Secher A., Lage K., Nordsborg N.B., Dmytriyev A., Lundby C.,
RA   Olsen J.V.;
RT   "Quantitative maps of protein phosphorylation sites across 14 different rat
RT   organs and tissues.";
RL   Nat. Commun. 3:876-876(2012).
CC   -!- FUNCTION: Protein tyrosine-protein phosphatase required for T-cell
CC       activation through the antigen receptor. Acts as a positive regulator
CC       of T-cell coactivation upon binding to DPP4. The first PTPase domain
CC       has enzymatic activity, while the second one seems to affect the
CC       substrate specificity of the first one. Upon T-cell activation,
CC       recruits and dephosphorylates SKAP1 and FYN (By similarity).
CC       Dephosphorylates LYN, and thereby modulates LYN activity (By
CC       similarity). {ECO:0000250}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=H2O + O-phospho-L-tyrosyl-[protein] = L-tyrosyl-[protein] +
CC         phosphate; Xref=Rhea:RHEA:10684, Rhea:RHEA-COMP:10136, Rhea:RHEA-
CC         COMP:10137, ChEBI:CHEBI:15377, ChEBI:CHEBI:43474, ChEBI:CHEBI:46858,
CC         ChEBI:CHEBI:82620; EC=3.1.3.48; Evidence={ECO:0000255|PROSITE-
CC         ProRule:PRU10044};
CC   -!- SUBUNIT: Interacts with SKAP1. Interacts with DPP4; the interaction is
CC       enhanced in an interleukin-12-dependent manner in activated
CC       lymphocytes. Binds GANAB and PRKCSH (By similarity). Interacts with
CC       CD53; this interaction stabilizes PTPRC on the membrane and is required
CC       for optimal phosphatase activity (By similarity).
CC       {ECO:0000250|UniProtKB:P06800, ECO:0000250|UniProtKB:P08575}.
CC   -!- SUBCELLULAR LOCATION: Cell membrane {ECO:0000250|UniProtKB:P08575};
CC       Single-pass type I membrane protein {ECO:0000255}. Membrane raft
CC       {ECO:0000250|UniProtKB:P08575}. Synapse {ECO:0000250|UniProtKB:P08575}.
CC       Note=Colocalized with DPP4 in membrane rafts.
CC       {ECO:0000250|UniProtKB:P08575}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=5;
CC         Comment=Additional isoforms seem to exist.;
CC       Name=1; Synonyms=L-CA variant 4;
CC         IsoId=P04157-1; Sequence=Displayed;
CC       Name=2; Synonyms=L-CA variant 1;
CC         IsoId=P04157-2; Sequence=VSP_005167;
CC       Name=3; Synonyms=L-CA variant 2;
CC         IsoId=P04157-3; Sequence=VSP_005166;
CC       Name=4; Synonyms=L-CA variant 3;
CC         IsoId=P04157-4; Sequence=VSP_005165, VSP_005168;
CC       Name=5;
CC         IsoId=P04157-5; Sequence=VSP_026163;
CC   -!- TISSUE SPECIFICITY: Isoform 1 and isoform 2 are found in thymocyte and
CC       lymph node. Isoform 4 and isoform 3 are found in the lymph nod.
CC   -!- DOMAIN: The first PTPase domain interacts with SKAP1. {ECO:0000250}.
CC   -!- PTM: Heavily N- and O-glycosylated.
CC   -!- PTM: The cytoplasmic domain contains potential phosphorylation sites.
CC   -!- SIMILARITY: Belongs to the protein-tyrosine phosphatase family.
CC       Receptor class 1/6 subfamily. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; CB793707; -; NOT_ANNOTATED_CDS; mRNA.
DR   EMBL; Y00065; CAA68272.1; -; mRNA.
DR   EMBL; Y00065; CAA68273.1; -; mRNA.
DR   EMBL; Y00065; CAA68274.1; -; mRNA.
DR   EMBL; Y00065; CAA68275.1; -; mRNA.
DR   EMBL; M25820; AAA41518.1; -; mRNA.
DR   EMBL; M25821; AAA41519.1; -; mRNA.
DR   EMBL; M25822; AAA41520.1; -; mRNA.
DR   EMBL; M25823; AAA41521.1; -; mRNA.
DR   PIR; A45854; A45854.
DR   RefSeq; NP_001103357.1; NM_001109887.2. [P04157-4]
DR   RefSeq; NP_001103358.1; NM_001109888.2. [P04157-5]
DR   RefSeq; NP_001103359.1; NM_001109889.2. [P04157-3]
DR   RefSeq; NP_612516.2; NM_138507.3. [P04157-1]
DR   RefSeq; XP_006249972.1; XM_006249910.2.
DR   PDB; 5FN8; X-ray; 2.45 A; A/B=357-546.
DR   PDBsum; 5FN8; -.
DR   AlphaFoldDB; P04157; -.
DR   SMR; P04157; -.
DR   BioGRID; 246829; 1.
DR   IntAct; P04157; 2.
DR   MINT; P04157; -.
DR   STRING; 10116.ENSRNOP00000063859; -.
DR   GlyCosmos; P04157; 16 sites, No reported glycans.
DR   GlyGen; P04157; 16 sites.
DR   iPTMnet; P04157; -.
DR   PhosphoSitePlus; P04157; -.
DR   PaxDb; 10116-ENSRNOP00000063859; -.
DR   Ensembl; ENSRNOT00000060292.5; ENSRNOP00000057042.2; ENSRNOG00000000655.9. [P04157-3]
DR   Ensembl; ENSRNOT00000064785.4; ENSRNOP00000063859.1; ENSRNOG00000000655.9. [P04157-1]
DR   GeneID; 24699; -.
DR   KEGG; rno:24699; -.
DR   UCSC; RGD:3451; rat. [P04157-1]
DR   AGR; RGD:3451; -.
DR   CTD; 5788; -.
DR   RGD; 3451; Ptprc.
DR   eggNOG; KOG4228; Eukaryota.
DR   GeneTree; ENSGT00940000159457; -.
DR   HOGENOM; CLU_001645_2_1_1; -.
DR   InParanoid; P04157; -.
DR   OMA; ISANKPC; -.
DR   OrthoDB; 2875525at2759; -.
DR   PhylomeDB; P04157; -.
DR   TreeFam; TF351829; -.
DR   Reactome; R-RNO-202427; Phosphorylation of CD3 and TCR zeta chains.
DR   Reactome; R-RNO-416700; Other semaphorin interactions.
DR   Reactome; R-RNO-6798695; Neutrophil degranulation.
DR   PRO; PR:P04157; -.
DR   Proteomes; UP000002494; Chromosome 13.
DR   Bgee; ENSRNOG00000000655; Expressed in spleen and 19 other cell types or tissues.
DR   GO; GO:0032059; C:bleb; ISO:RGD.
DR   GO; GO:0071944; C:cell periphery; ISO:RGD.
DR   GO; GO:0009986; C:cell surface; IDA:RGD.
DR   GO; GO:0009898; C:cytoplasmic side of plasma membrane; TAS:RGD.
DR   GO; GO:0009897; C:external side of plasma membrane; ISO:RGD.
DR   GO; GO:0005925; C:focal adhesion; ISS:UniProtKB.
DR   GO; GO:0098857; C:membrane microdomain; ISO:RGD.
DR   GO; GO:0045121; C:membrane raft; ISO:RGD.
DR   GO; GO:0005886; C:plasma membrane; IDA:UniProtKB.
DR   GO; GO:0045202; C:synapse; IEA:UniProtKB-SubCell.
DR   GO; GO:0030506; F:ankyrin binding; ISO:RGD.
DR   GO; GO:0043395; F:heparan sulfate proteoglycan binding; ISO:RGD.
DR   GO; GO:0008201; F:heparin binding; ISO:RGD.
DR   GO; GO:0019901; F:protein kinase binding; ISS:UniProtKB.
DR   GO; GO:0019887; F:protein kinase regulator activity; TAS:RGD.
DR   GO; GO:0004725; F:protein tyrosine phosphatase activity; IGI:ARUK-UCL.
DR   GO; GO:0005102; F:signaling receptor binding; ISO:RGD.
DR   GO; GO:0030507; F:spectrin binding; ISO:RGD.
DR   GO; GO:0005001; F:transmembrane receptor protein tyrosine phosphatase activity; TAS:RGD.
DR   GO; GO:0046633; P:alpha-beta T cell proliferation; ISO:RGD.
DR   GO; GO:0030183; P:B cell differentiation; ISO:RGD.
DR   GO; GO:0042100; P:B cell proliferation; ISS:UniProtKB.
DR   GO; GO:0050853; P:B cell receptor signaling pathway; ISS:UniProtKB.
DR   GO; GO:0048539; P:bone marrow development; ISO:RGD.
DR   GO; GO:0044770; P:cell cycle phase transition; ISO:RGD.
DR   GO; GO:0051607; P:defense response to virus; ISS:UniProtKB.
DR   GO; GO:0016311; P:dephosphorylation; ISS:UniProtKB.
DR   GO; GO:0097191; P:extrinsic apoptotic signaling pathway; ISO:RGD.
DR   GO; GO:0042492; P:gamma-delta T cell differentiation; ISO:RGD.
DR   GO; GO:0002244; P:hematopoietic progenitor cell differentiation; ISO:RGD.
DR   GO; GO:0034113; P:heterotypic cell-cell adhesion; ISO:RGD.
DR   GO; GO:0007159; P:leukocyte cell-cell adhesion; ISO:RGD.
DR   GO; GO:0000165; P:MAPK cascade; ISO:RGD.
DR   GO; GO:0001779; P:natural killer cell differentiation; ISO:RGD.
DR   GO; GO:0006933; P:negative regulation of cell adhesion involved in substrate-bound cell migration; ISO:RGD.
DR   GO; GO:0001960; P:negative regulation of cytokine-mediated signaling pathway; ISS:UniProtKB.
DR   GO; GO:0070373; P:negative regulation of ERK1 and ERK2 cascade; ISO:RGD.
DR   GO; GO:0032703; P:negative regulation of interleukin-2 production; ISO:RGD.
DR   GO; GO:0050732; P:negative regulation of peptidyl-tyrosine phosphorylation; ISO:RGD.
DR   GO; GO:0031953; P:negative regulation of protein autophosphorylation; ISO:RGD.
DR   GO; GO:0006469; P:negative regulation of protein kinase activity; ISS:UniProtKB.
DR   GO; GO:0001915; P:negative regulation of T cell mediated cytotoxicity; ISS:UniProtKB.
DR   GO; GO:0045060; P:negative thymic T cell selection; ISO:RGD.
DR   GO; GO:0044855; P:plasma membrane raft distribution; ISO:RGD.
DR   GO; GO:0046641; P:positive regulation of alpha-beta T cell proliferation; ISO:RGD.
DR   GO; GO:0050857; P:positive regulation of antigen receptor-mediated signaling pathway; ISS:UniProtKB.
DR   GO; GO:0030890; P:positive regulation of B cell proliferation; ISO:RGD.
DR   GO; GO:0070374; P:positive regulation of ERK1 and ERK2 cascade; ISO:RGD.
DR   GO; GO:2001238; P:positive regulation of extrinsic apoptotic signaling pathway; ISO:RGD.
DR   GO; GO:0060369; P:positive regulation of Fc receptor mediated stimulatory signaling pathway; ISO:RGD.
DR   GO; GO:0045588; P:positive regulation of gamma-delta T cell differentiation; ISO:RGD.
DR   GO; GO:2000473; P:positive regulation of hematopoietic stem cell migration; ISO:RGD.
DR   GO; GO:0002925; P:positive regulation of humoral immune response mediated by circulating immunoglobulin; ISO:RGD.
DR   GO; GO:0002639; P:positive regulation of immunoglobulin production; ISO:RGD.
DR   GO; GO:0032743; P:positive regulation of interleukin-2 production; ISO:RGD.
DR   GO; GO:0048304; P:positive regulation of isotype switching to IgG isotypes; ISO:RGD.
DR   GO; GO:0043410; P:positive regulation of MAPK cascade; ISO:RGD.
DR   GO; GO:0050731; P:positive regulation of peptidyl-tyrosine phosphorylation; ISO:RGD.
DR   GO; GO:0050766; P:positive regulation of phagocytosis; ISO:RGD.
DR   GO; GO:2000648; P:positive regulation of stem cell proliferation; ISO:RGD.
DR   GO; GO:0045582; P:positive regulation of T cell differentiation; ISO:RGD.
DR   GO; GO:0001916; P:positive regulation of T cell mediated cytotoxicity; ISO:RGD.
DR   GO; GO:0002711; P:positive regulation of T cell mediated immunity; ISO:RGD.
DR   GO; GO:0042102; P:positive regulation of T cell proliferation; ISS:UniProtKB.
DR   GO; GO:0032760; P:positive regulation of tumor necrosis factor production; ISO:RGD.
DR   GO; GO:0045059; P:positive thymic T cell selection; ISO:RGD.
DR   GO; GO:0006470; P:protein dephosphorylation; ISS:UniProtKB.
DR   GO; GO:0051726; P:regulation of cell cycle; ISS:UniProtKB.
DR   GO; GO:2001236; P:regulation of extrinsic apoptotic signaling pathway; ISO:RGD.
DR   GO; GO:0010468; P:regulation of gene expression; IGI:ARUK-UCL.
DR   GO; GO:0002923; P:regulation of humoral immune response mediated by circulating immunoglobulin; ISO:RGD.
DR   GO; GO:0032677; P:regulation of interleukin-8 production; ISO:RGD.
DR   GO; GO:0050764; P:regulation of phagocytosis; ISO:RGD.
DR   GO; GO:0046425; P:regulation of receptor signaling pathway via JAK-STAT; ISO:RGD.
DR   GO; GO:0051209; P:release of sequestered calcium ion into cytosol; ISS:UniProtKB.
DR   GO; GO:1904044; P:response to aldosterone; IEP:RGD.
DR   GO; GO:0010332; P:response to gamma radiation; IDA:RGD.
DR   GO; GO:0048864; P:stem cell development; ISO:RGD.
DR   GO; GO:0030217; P:T cell differentiation; ISS:UniProtKB.
DR   GO; GO:0042098; P:T cell proliferation; ISO:RGD.
DR   GO; GO:0050852; P:T cell receptor signaling pathway; IGI:ARUK-UCL.
DR   CDD; cd00063; FN3; 2.
DR   CDD; cd14558; R-PTP-C-2; 1.
DR   CDD; cd14557; R-PTPc-C-1; 1.
DR   Gene3D; 2.60.40.10; Immunoglobulins; 2.
DR   Gene3D; 3.90.190.10; Protein tyrosine phosphatase superfamily; 2.
DR   InterPro; IPR003961; FN3_dom.
DR   InterPro; IPR036116; FN3_sf.
DR   InterPro; IPR013783; Ig-like_fold.
DR   InterPro; IPR029021; Prot-tyrosine_phosphatase-like.
DR   InterPro; IPR050348; Protein-Tyr_Phosphatase.
DR   InterPro; IPR000242; PTP_cat.
DR   InterPro; IPR024739; PTP_recept_N.
DR   InterPro; IPR016335; Ptprc.
DR   InterPro; IPR016130; Tyr_Pase_AS.
DR   InterPro; IPR003595; Tyr_Pase_cat.
DR   InterPro; IPR000387; Tyr_Pase_dom.
DR   PANTHER; PTHR19134; RECEPTOR-TYPE TYROSINE-PROTEIN PHOSPHATASE; 1.
DR   PANTHER; PTHR19134:SF539; RECEPTOR-TYPE TYROSINE-PROTEIN PHOSPHATASE C; 1.
DR   Pfam; PF12567; CD45; 1.
DR   Pfam; PF00041; fn3; 2.
DR   Pfam; PF12453; PTP_N; 1.
DR   Pfam; PF00102; Y_phosphatase; 2.
DR   PIRSF; PIRSF002004; Leukocyte_common_antigen; 1.
DR   PRINTS; PR00700; PRTYPHPHTASE.
DR   SMART; SM00060; FN3; 2.
DR   SMART; SM00194; PTPc; 2.
DR   SMART; SM00404; PTPc_motif; 2.
DR   SUPFAM; SSF52799; (Phosphotyrosine protein) phosphatases II; 2.
DR   SUPFAM; SSF49265; Fibronectin type III; 1.
DR   PROSITE; PS50853; FN3; 2.
DR   PROSITE; PS00383; TYR_PHOSPHATASE_1; 1.
DR   PROSITE; PS50056; TYR_PHOSPHATASE_2; 2.
DR   PROSITE; PS50055; TYR_PHOSPHATASE_PTP; 2.
PE   1: Evidence at protein level;
KW   3D-structure; Alternative splicing; Cell membrane; Glycoprotein; Hydrolase;
KW   Membrane; Phosphoprotein; Protein phosphatase; Reference proteome; Repeat;
KW   Signal; Synapse; Transmembrane; Transmembrane helix.
FT   SIGNAL          1..23
FT   CHAIN           24..1273
FT                   /note="Receptor-type tyrosine-protein phosphatase C"
FT                   /id="PRO_0000025472"
FT   TOPO_DOM        24..546
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        547..567
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        568..1273
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   DOMAIN          361..452
FT                   /note="Fibronectin type-III 1"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00316"
FT   DOMAIN          453..545
FT                   /note="Fibronectin type-III 2"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00316"
FT   DOMAIN          622..881
FT                   /note="Tyrosine-protein phosphatase 1"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00160"
FT   DOMAIN          913..1196
FT                   /note="Tyrosine-protein phosphatase 2"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00160"
FT   REGION          45..192
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          960..984
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          1219..1273
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        46..114
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        137..192
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   ACT_SITE        822
FT                   /note="Phosphocysteine intermediate"
FT                   /evidence="ECO:0000250"
FT   ACT_SITE        1137
FT                   /note="Phosphocysteine intermediate"
FT                   /evidence="ECO:0000250"
FT   BINDING         790
FT                   /ligand="substrate"
FT                   /evidence="ECO:0000250"
FT   BINDING         822..828
FT                   /ligand="substrate"
FT                   /evidence="ECO:0000250"
FT   BINDING         866
FT                   /ligand="substrate"
FT                   /evidence="ECO:0000250"
FT   MOD_RES         652
FT                   /note="Phosphotyrosine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         944
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:P08575"
FT   MOD_RES         963
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         966
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         970
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         973
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         974
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         978
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         1209
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         1266
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:P08575"
FT   CARBOHYD        62
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        142
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        153
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        164
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        178
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        200
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        245
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        250
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        271
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        282
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        327
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        333
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        371
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        374
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        471
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        502
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   VAR_SEQ         30..161
FT                   /note="Missing (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:2440674"
FT                   /id="VSP_005167"
FT   VAR_SEQ         30..120
FT                   /note="Missing (in isoform 3)"
FT                   /evidence="ECO:0000303|PubMed:2440674, ECO:0000303|Ref.3"
FT                   /id="VSP_005166"
FT   VAR_SEQ         30..71
FT                   /note="Missing (in isoform 4)"
FT                   /evidence="ECO:0000303|PubMed:2440674, ECO:0000303|Ref.1,
FT                   ECO:0000303|Ref.3"
FT                   /id="VSP_005165"
FT   VAR_SEQ         72..161
FT                   /note="Missing (in isoform 5)"
FT                   /evidence="ECO:0000303|Ref.3"
FT                   /id="VSP_026163"
FT   VAR_SEQ         121..161
FT                   /note="Missing (in isoform 4)"
FT                   /evidence="ECO:0000303|PubMed:2440674, ECO:0000303|Ref.1,
FT                   ECO:0000303|Ref.3"
FT                   /id="VSP_005168"
FT   CONFLICT        56
FT                   /note="S -> R (in Ref. 3; AAA41518/AAA41521)"
FT                   /evidence="ECO:0000305"
FT   STRAND          385..387
FT                   /evidence="ECO:0007829|PDB:5FN8"
FT   STRAND          423..426
FT                   /evidence="ECO:0007829|PDB:5FN8"
FT   STRAND          445..448
FT                   /evidence="ECO:0007829|PDB:5FN8"
FT   STRAND          458..464
FT                   /evidence="ECO:0007829|PDB:5FN8"
FT   STRAND          466..468
FT                   /evidence="ECO:0007829|PDB:5FN8"
FT   STRAND          470..475
FT                   /evidence="ECO:0007829|PDB:5FN8"
FT   STRAND          486..493
FT                   /evidence="ECO:0007829|PDB:5FN8"
FT   STRAND          496..510
FT                   /evidence="ECO:0007829|PDB:5FN8"
FT   STRAND          518..526
FT                   /evidence="ECO:0007829|PDB:5FN8"
FT   STRAND          535..540
FT                   /evidence="ECO:0007829|PDB:5FN8"
SQ   SEQUENCE   1273 AA;  143269 MW;  EDFA48100ACF2CB2 CRC64;
     MYLWLKLLAF SLALLGPEVF VTGQGTTDDG LDTTEIVLLP QTDPLPARTT EFTPPSISER
     GNGSSETTYL PGFSSTLMPH LTPQPDSQTP SARGADTQTL SSQADLTTLT AAPSGETDPP
     GVPEESTVPE TFPGGTPILA RNSTAPSPTH TSNVSTTDIS SGANLTTPAP STLGFASNTT
     TSTEIATPQT KPSCDEKFGN VTVRYIYDDS SKNFNANLEG DKKPKCEYTD CEKELKNLPE
     CSQKNVTLSN GSCTPDKIIN LDVPPGTHNF NLTNCTPDIE ANTSICLEWK IKNKFTCDIQ
     KISYNFRCTP EMKTFALDKH GTLWLHNLTV RTNYTCAAEV LYNNVILLKQ DRRVQTDFGT
     PEMLPHVQCK NSTNSTTLVS WAEPASKHHG YILCYKKTPS EKCENLANDV NSFEVKNLRP
     YTEYTVSLFA YVIGRVQRNG PAKDCNFRTK AARPGKVNGM KTSRASDNSI NVTCNSPYEI
     NGPEARYILE VKSGGSLVKT FNQSTCKFVV DNLYYSTDYE FLVYFYNGEY LGDPEIKPQS
     TSYNSKALII FLVFLIIVTS IALLVVLYKI YDLRKKRSSN LDEQQELVER DEEKQLINVD
     PIHSDLLLET YKRKIADEGR LFLAEFQSIP RVFSKFPIKD ARKSQNQNKN RYVDILPYDY
     NRVELSEING DAGSTYINAS YIDGFKEPRK YIAAQGPRDE TVDDFWKMIW EQKATVIVMV
     TRCEEGNRNK CAEYWPCMEE GTRTFRDVVV TINDHKRCPD YIIQKLSIAH KKEKATGREV
     THIQFTSWPD HGVPEDPHLL LKLRRRVNAF SNFFSGPIVV HCSAGVGRTG TYIGIDAMLE
     SLEAEGKVDV YGYVVNLRRQ RCLMVQVEAQ YILIHQALVE YNQFGETEVN LSELHSCLQN
     LKKRDPPSDP SPLEAEYQRL PSYRSWRTQH IGNQEENKKK NRSSNVVPYD FNRVPLKHEL
     EMSKESEAES DESSDEDSDS EETSKYINAS FVMSYWKPEM MIAAQGPLKE TIGDFWQMIF
     QRKVKVIVML TELMSGDQEV CAQYWGEGKQ TYGDMEVMLK DTNKSSAYIL RAFELRHSKR
     KEPRTVYQYQ CTTWKGEELP AEPKDLVTLI QNIKQKLPKS GSEGMKYHKH ASILVHCRDG
     SQQTGLFCAL FNLLESAETE DVVDVFQVVK SLRKARPGMV GSFEQYQFLY DIMASIYPTQ
     NGQVKKANSQ DKIEFHNEVD GAKQDANCVQ PADPLNKAQE DSKEVGASEP ASGSEEPEHS
     ANGPMSPALT PSS
//
